Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ISRCTN10216938) titled 'Pharmacogenetics to avoid loss of hearing UK' on March 2.
Study Type: Observational
Study Design:
Multi-centre implementation study (Screening)
Primary Sponsor: University of Manchester
Condition:
Use of a genetic test to detect the m.1555A>G variant associated with aminoglycoside-induced hearing loss in neonatal care units
Neonatal Diseases
Intervention:
This study involves a genetic test to detect the m.1555A>G variant associated with aminoglycoside-induced hearing loss. All babies admitted to the participating neonatal care units during the study period will be tested for this variant before antibiotic ...